We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+0.55%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$48B
AUM Growth
-$1.59B
Cap. Flow
-$1.46B
Cap. Flow %
-3.05%
Top 10 Hldgs %
24.06%
Holding
1,904
New
84
Increased
534
Reduced
502
Closed
55

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$60.6M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$50.8M
3
MA icon
Mastercard
MA
+$43.1M
4
ADI icon
Analog Devices
ADI
+$40.3M
5
AVGO icon
Broadcom
AVGO
+$40.1M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$92.3M
2
NVDA icon
NVIDIA
NVDA
+$92.1M
3
LLY icon
Eli Lilly
LLY
+$80.8M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$74.2M
5
MSFT icon
Microsoft
MSFT
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 24.14%
2 Financials 15.08%
3 Healthcare 14.69%
4 Consumer Discretionary 11.11%
5 Communication Services 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPF icon
1551
Central Pacific Financial
CPF
$1.02B
$686K ﹤0.01%
26,700
RDNT icon
1552
RadNet
RDNT
$4.88B
$686K ﹤0.01%
23,400
+11,400
+95% +$366K
LL
1553
DELISTED
LL Flooring Holdings, Inc.
LL
$682K ﹤0.01%
36,496
PETS icon
1554
PetMed Express
PETS
$42.5M
$678K ﹤0.01%
25,217
PNTG icon
1555
Pennant Group
PNTG
$1.44B
$678K ﹤0.01%
24,152
ORGO icon
1556
Organogenesis Holdings
ORGO
$331M
$675K ﹤0.01%
47,400
+5,700
+14% +$88.5K
ANIK icon
1557
Anika Therapeutics
ANIK
$202M
$672K ﹤0.01%
15,800
KOP icon
1558
Koppers
KOP
$970M
$671K ﹤0.01%
21,467
MTCH icon
1559
Match Group
MTCH
$9.19B
$667K ﹤0.01%
4,250
+3,055
+256% +$465K
EPIX
1560
DELISTED
ESSA Pharma
EPIX
$665K ﹤0.01%
83,068
-95,000
-53% -$1.51M
INGN icon
1561
Inogen
INGN
$175M
$665K ﹤0.01%
15,435
NTUS
1562
DELISTED
Natus Medical Inc
NTUS
$661K ﹤0.01%
26,337
KKR icon
1563
KKR & Co
KKR
$92B
$657K ﹤0.01%
10,785
-7,690
-42% -$483K
VIVO
1564
DELISTED
Meridian Bioscience Inc
VIVO
$656K ﹤0.01%
34,100
HWKN icon
1565
Hawkins
HWKN
$2.96B
$652K ﹤0.01%
18,702
DYN icon
1566
Dyne Therapeutics
DYN
$4.25B
$650K ﹤0.01%
40,000
CUBE icon
1567
CubeSmart
CUBE
$9.79B
$649K ﹤0.01%
13,390
-2,565
-16% -$129K
SRDX
1568
DELISTED
Surmodics
SRDX
$645K ﹤0.01%
11,600
TALO icon
1569
Talos Energy
TALO
$2.35B
$642K ﹤0.01%
46,600
+1,500
+3% +$18.3K
ELF icon
1570
e.l.f. Beauty
ELF
$4.99B
$633K ﹤0.01%
21,800
CVGW
1571
DELISTED
Calavo Growers
CVGW
$627K ﹤0.01%
16,402
CVE icon
1572
Cenovus Energy
CVE
$52.5B
$626K ﹤0.01%
61,734
+3,300
+6% +$28.2K
NX icon
1573
Quanex
NX
$881M
$625K ﹤0.01%
29,184
ACI icon
1574
Albertsons Companies
ACI
$5.61B
$620K ﹤0.01%
19,905
-19,095
-49% -$502K
ATNI icon
1575
ATN International
ATNI
$370M
$618K ﹤0.01%
13,198

Similar funds

Ensign Peak Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Ensign Peak Advisors held 1,904 positions worth $48B, down 3.2% from $49.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Ensign Peak Advisors withdrew a net $1.46B in Q3 2021, closing 55 positions and reducing 502 holdings. Its most notable exit was Root, an estimated $29.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ensign Peak Advisors opened a new position in State Street SPDR S&P Biotech ETF worth $37.7M.

  • Ensign Peak Advisors's largest Q3 2021 buy was State Street SPDR S&P Biotech ETF: 300,000 shares worth $37.7M.
  • Ensign Peak Advisors added most to AbbVie in Q3 2021, an estimated $60.6M increase.
  • Ensign Peak Advisors's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $92.3M.
  • Ensign Peak Advisors fully exited Root in Q3 2021, selling an estimated $29.6M.
  • Ensign Peak Advisors's ten largest holdings make up 24% of its $48B portfolio in Q3 2021.
  • Ensign Peak Advisors opened 84 new positions and closed 55 in Q3 2021.
  • Ensign Peak Advisors's portfolio value fell 3.2% quarter-over-quarter to $48B.

Based on Ensign Peak Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.